Evidence map›Paper›PMID 25411170›Full record

ArticleJournal of clinical microbiology2015

Detection of chikungunya virus antigen by a novel rapid immunochromatographic test.

Tamaki Okabayashi, Tadahiro Sasaki, Promsin Masrinoul, Nantarat Chantawat, Sutee Yoksan, Narong Nitatpattana, Sarunyou Chusri, Ronald E Morales Vargas, Marc Grandadam, Paul T Brey and 15 more

Erratum issuedOpen access · bronzeAbstract readEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Current Status of Chikungunya in India.Frontiers in microbiology · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 8 institutions in 4 countries.

Tamaki OkabayashiMahidol-Osaka Center for Infectious Diseases (MOCID), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand Department of Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan tamaoka@biken.osaka-u.ac.jp.
Tadahiro SasakiDepartment of Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Promsin MasrinoulMahidol-Osaka Center for Infectious Diseases (MOCID), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand Center for Vaccine Development, Mahidol University, Nakhon Pathom, Thailand.
Nantarat ChantawatMahidol-Osaka Center for Infectious Diseases (MOCID), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Sutee YoksanCenter for Vaccine Development, Mahidol University, Nakhon Pathom, Thailand.
Narong NitatpattanaCenter for Vaccine Development, Mahidol University, Nakhon Pathom, Thailand.
Sarunyou ChusriDivision of Infectious Disease, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand.
Ronald E Morales VargasDepartment of Medical Entomology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Marc GrandadamInstitute Pasteur du Laos, Vientiane, Lao People's Democratic Republic.
Paul T BreyInstitute Pasteur du Laos, Vientiane, Lao People's Democratic Republic.
Soegeng SoegijantoIndonesia-Japan Collaboration Research Center for Emerging and Re-emerging Infectious Diseases, Institute of Tropical Diseases, Airlangga University, Surabaya, Indonesia.
Kris Cahyo MulyantnoIndonesia-Japan Collaboration Research Center for Emerging and Re-emerging Infectious Diseases, Institute of Tropical Diseases, Airlangga University, Surabaya, Indonesia.
Siti ChurrotinIndonesia-Japan Collaboration Research Center for Emerging and Re-emerging Infectious Diseases, Institute of Tropical Diseases, Airlangga University, Surabaya, Indonesia.
Tomohiro KotakiIndonesia-Japan Collaboration Research Center for Emerging and Re-emerging Infectious Diseases, Institute of Tropical Diseases, Airlangga University, Surabaya, Indonesia Center for Infectious Diseases, Kobe University Graduate School of Medicine, Hyogo, Japan.
Oumar FayeArboviruses and Viral Hemorrhagic Fever Unit, Institute Pasteur de Dakar, Dakar, Senegal.
Ousmane FayeArboviruses and Viral Hemorrhagic Fever Unit, Institute Pasteur de Dakar, Dakar, Senegal.
Abdourahmane SowArboviruses and Viral Hemorrhagic Fever Unit, Institute Pasteur de Dakar, Dakar, Senegal.
Amadou Alpha SallArboviruses and Viral Hemorrhagic Fever Unit, Institute Pasteur de Dakar, Dakar, Senegal.
Orapim PuipromMahidol-Osaka Center for Infectious Diseases (MOCID), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Panjaporn ChaichanaMahidol-Osaka Center for Infectious Diseases (MOCID), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Takeshi KurosuDepartment of Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Seiji KatoAlfresa Pharma Corporation, Osaka, Japan.
Mieko KosakaAlfresa Pharma Corporation, Osaka, Japan Arkray Incorporated, Kyoto, Japan.
Pongrama RamasootaCenter of Excellence for Antibody Research, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Kazuyoshi IkutaDepartment of Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Mahidol University · THInstitut Pasteur de Dakar · SNOsaka University · JPAirlangga University · IDArkray (Japan) · JPKobe University · JPMahidol Oxford Tropical Medicine Research Unit · THPrince of Songkla University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chikungunya fever is a mosquito-borne disease of key public health importance in tropical and subtropical countries. Although severe joint pain is the most distinguishing feature of chikungunya fever, diagnosis remains difficult because the symptoms of chikungunya fever are shared by many pathogens, including dengue fever. The present study aimed to develop a new immunochromatographic diagnosis test for the detection of chikungunya virus antigen in serum. Mice were immunized with isolates from patients with Thai chikungunya fever, East/Central/South African genotype, to produce mouse monoclonal antibodies against chikungunya virus. Using these monoclonal antibodies, a new diagnostic test was developed and evaluated for the detection of chikungunya virus. The newly developed diagnostic test reacted with not only the East/Central/South African genotype but also with the Asian and West African genotypes of chikungunya virus. Testing of sera from patients suspected to have chikungunya fever in Thailand (n = 50), Laos (n = 54), Indonesia (n = 2), and Senegal (n = 6) revealed sensitivity, specificity, and real-time PCR (RT-PCR) agreement values of 89.4%, 94.4%, and 91.1%, respectively. In our study using serial samples, a new diagnostic test showed high agreement with the RT-PCR within the first 5 days after onset. A rapid diagnostic test was developed using mouse monoclonal antibodies that react with chikungunya virus envelope proteins. The diagnostic accuracy of our test is clinically acceptable for chikungunya fever in the acute phase.

Indexed as

AnimalsAntibodies, MonoclonalAntibodies, ViralAntigens, ViralChikungunya FeverChikungunya virusChromatography, AffinityDiagnostic Tests, RoutineHumansIndonesiaMice, Inbred BALB CSenegalSensitivity and SpecificitySerumThailandTime FactorsAntibodies, MonoclonalAntibodies, ViralAntigens, Viral

Identifiers

PMID25411170
PMCPMC4298496
OpenAlexW1964822794

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.